Heart failure & cardiomyopathies

Mortality in Patients With Hodgkin Lymphoma and Heart Failure: A Swedish Population-Based Study

JACC AdvPublished Patients with classical Hodgkin lymphoma (cHL) and subsequent heart failure (HF) were matched 1:2 with comparators with HF

Authors' conclusion

cHL was associated with higher all-cause mortality following HF diagnosis. CV-specific mortality was significantly higher for patients with HF ≥10 years after cHL, possibly highlighting the impact of late treatment toxicity, although careful interpretation is warranted given the strong competing risk of lymphoma-related deaths.

Study context

Population
Patients with classical Hodgkin lymphoma (cHL) and subsequent heart failure (HF), and comparators with HF, 2000 to 2022
Participants
257 vs 514
Comparison
All-cause mortality following HF diagnosis between patients with prior cHL and comparators
  • cHLn = 257
  • Comparatorsn = 514reference
Outcome
Deaths
Follow-up
Median 2.5 years for cHL and 3.3 years for comparators
Methodological detailsmatched 1:2 on sex, birth year, year of HF, and contact type (inpatient/outpatient), flexible parametric survival models adjusted for matching variables
  • Matched 1:2 on sex, birth year, year of HF, and contact type (inpatient/outpatient)
  • Flexible parametric survival models adjusted for matching variables

Main finding

As reported in the abstract

Further findings

OutcomeHR (95% CI)
All-cause mortalityHigher with prior cHL1.81 (1.44–2.26)
CV-specific mortality (explorative outcome)Overall; did not differ1.17 (0.78–1.75)
CV-specific mortality (explorative outcome)Patients with HF ≥10 years after cHL3.13 (1.71–5.73)
OutcomecHLComparators
Cause of death
Lymphoma-related death40%— not stated in the abstract
CV death— not stated in the abstract42%

— not stated in the abstract

Original publication

Mortality in Patients With Hodgkin Lymphoma and Heart Failure: A Swedish Population-Based Study. JACC Adv. Published 22 July 2026. doi:10.1016/j.jacadv.2026.103058

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.